Androgens and bone
Tóm tắt
Từ khóa
Tài liệu tham khảo
Albright, 1948, Metabolic bone disease: osteoporosis, 145
Riggs, 2002, Sex steroids and the construction and conservation of the adult skeleton, Endocr Rev, 23, 279, 10.1210/er.23.3.279
Khosla, 2002, Estrogen and the male skeleton, J Clin Endocrinol Metab, 87, 1443, 10.1210/jc.87.4.1443
Juul, 2001, The effects of estrogens on linear bone growth, Hum Reprod Update, 7, 303, 10.1093/humupd/7.3.303
Falahati-Nini, 2000, Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men, J Clin Invest, 106, 1553, 10.1172/JCI10942
Leder, 2003, Differential effects of androgens and estrogens on bone turnover in normal men, J Clin Endocrinol Metab, 88, 204, 10.1210/jc.2002-021036
Carrascosa, 1990, Biological effects of androgens and identification of specific dihydrotestosterone-binding sites in cultured human fetal epiphyseal chondrocytes, J Clin Endocrinol Metab, 70, 134, 10.1210/jcem-70-1-134
Abu, 1997, The localization of androgen receptors in human bone, J Clin Endocrinol Metab, 82, 3493, 10.1210/jc.82.10.3493
Ben-Hur, 1997, Estrogen, progesterone and testosterone receptors in human fetal cartilaginous tissue: immunohistochemical studies, Calcif Tissue Int, 60, 520, 10.1007/s002239900274
van der Eerden, 2002, Gender differences in expression of androgen receptor in tibial growth plate and metaphyseal bone of the rat, Bone, 30, 891, 10.1016/S8756-3282(02)00723-8
Bord, 2001, Estrogen receptors α and β are differentially expressed in developing human bone, J Clin Endocrinol Metab, 86, 2309, 10.1210/jc.86.5.2309
Nilsson, 1999, Demonstration of estrogen receptor-β immunoreactivity in human growth plate cartilage, J Clin Endocrinol Metab, 84, 370, 10.1210/jc.84.1.370
Colvard, 1989, Identification of androgen receptors in normal human osteoblast-like cells, Proc Natl Acad Sci USA, 86, 854, 10.1073/pnas.86.3.854
Wiren, 1997, Transcriptional up-regulation of the human androgen receptor by androgen in bone cells, Endocrinology, 138, 2291, 10.1210/en.138.6.2291
Bland, 2000, steroid hormone receptor expression and action in bone, Clin Sci (Lond), 98, 217, 10.1042/CS19990252
Kasperk, 1997, Skeletal site-dependent expression of the androgen receptor in human osteoblastic cell populations, Calcif Tissue Int, 61, 464, 10.1007/s002239900369
Wiren, 1999, Homologous androgen receptor up-regulation in osteoblastic cells may be associated with enhanced functional androgen responsiveness, Endocrinology, 140, 3114, 10.1210/en.140.7.3114
Pederson, 1999, Androgens regulate bone resorption activity of isolated osteoclasts in vitro, Proc Natl Acad Sci USA, 96, 505, 10.1073/pnas.96.2.505
Mizuno, 1994, Immuncytochemical identification of androgen receptor in mouse osteoclast-like cells, Calcif Tissue Int, 54, 325, 10.1007/BF00295958
Van der Eerden, 2002, Sex steroid metabolism in the tibial growth plate of the rat, Endocrinology, 143, 4048, 10.1210/en.2002-220093
Gruber, 1999, Expression of the vitamin D receptor, of estrogen and thyroid hormone receptor α- and β-isoforms, and of the androgen receptor in cultures of native mouse bone marrow and of stromal/osteoblastic cells, Bone, 24, 465, 10.1016/S8756-3282(99)00017-4
Braidman, 2001, Localization of estrogen receptor β protein expression in adult human bone, J Bone Miner Res, 16, 214, 10.1359/jbmr.2001.16.2.214
Ren, 1989, Direct administration of testosterone increases rat tibial epiphyseal growth plate width, Acta Endocrinol (Copenh), 121, 401, 10.1530/acta.0.1210401
Kerrigan, 1992, The impact of gonadal steroid hormone action on growth hormone secretion during childhood and adolescence, Endocr Rev, 13, 281
Kasperk, 1989, Androgens directly stimulate proliferation of bone cells in vitro, Endocrinology, 124, 1576, 10.1210/endo-124-3-1576
Kasperk, 1990, Studies of the mechanism by which androgens enhance mitogenesis and differentiation in bone cells, J Clin Endocrinol Metab, 71, 1322, 10.1210/jcem-71-5-1322
Kasperk, 1997, Gonadal and adrenal androgens are potent regulators of human bone cell metabolism in vitro, J Bone Miner Res, 12, 464, 10.1359/jbmr.1997.12.3.464
Hofbauer, 1998, Effects of gonadal and adrenal androgens in a novel androgen-responsive human osteoblastic cell line, J Cell Biochem, 71, 96, 10.1002/(SICI)1097-4644(19981001)71:1<96::AID-JCB10>3.0.CO;2-G
Bellido, 1995, Regulation of interleukin-6, osteoclastogenesis, and bone mass by androgens, J Clin Invest, 95, 2886, 10.1172/JCI117995
Pilbeam, 1990, Effects of androgens on parathyroid hormone and interleukin-1-stimulated prostaglandin production in cultured neonatal mouse calvariae, J Bone Miner Res, 5, 1183, 10.1002/jbmr.5650051114
Fukuyama, 1989, Direct modulation by estradiol of the response of human bone cells (SaOS-2) to human parathyroid hormone (PTH) and PTH-related protein, Endocrinology, 124, 397, 10.1210/endo-124-1-397
Pivirotto, 1995, Sex hormones mediate interleukin-1β production by human osteoblastic HOBIT cells, Mol Cell Endocrinol, 111, 67, 10.1016/0303-7207(95)03549-M
Hofbauer, 2002, Regulation of osteoprotegerin production by androgens and anti-androgens in human osteoblastic lineage cells, Eur J Endocrinol, 147, 269, 10.1530/eje.0.1470269
Suda, 1999, Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families, Endocr Rev, 20, 345, 10.1210/er.20.3.345
Huber, 2001, Androgens suppress osteoclast formation induced by RANKL and macrophage colony stimulating factor, Endocrinology, 142, 3800, 10.1210/en.142.9.3800
Smith, 2002, Osteoporosis during androgen deprivation therapy for prostate cancer, Urology, 60, 79, 10.1016/S0090-4295(02)01579-0
Stoch, 2001, Bone loss in men with prostate cancer treated with gonadotropin-releasing hormone agonists, J Clin Endocrinol Metab, 86, 2787, 10.1210/jc.86.6.2787
Smith, 2001, Pamidronate to prevent bone loss during androgen-deprivation therapy for prostate cancer, N Engl J Med, 345, 948, 10.1056/NEJMoa010845
Francis, 1999, The effects of testosterone on osteoporosis in men, Clin Endocrinol (Oxf), 50, 411, 10.1046/j.1365-2265.1999.00730.x
Jackson, 1987, Bone histomorphometry in hypogonadal and eugonadal men with spinal osteoporosis, J Clin Endocrinol Metab, 65, 53, 10.1210/jcem-65-1-53
Baran, 1978, Effect of testosterone therapy on bone formation in an osteoporotic hypogonadal male, Calcif Tissue Int, 26, 103, 10.1007/BF02013243
Francis, 1986, Osteoporosis in hypogonadal men: role of decreased plasma 1,25-dihydroxyvitamin D, calcium malabsorption, and low bone formation, Bone, 7, 261, 10.1016/8756-3282(86)90205-X
Baillie, 1992, Pathogenesis of vertebral crush fractures in men, Age Ageing, 21, 139, 10.1093/ageing/21.2.139
Stanley, 1991, Does hypogonadism contribute to the occurrence of a minimal trauma hip fracture in elderly men?, J Am Geriatr Soc, 39, 766, 10.1111/j.1532-5415.1991.tb02698.x
Mellstrom, 2006, Free testosterone is an independent predictor of BMD and prevalent fractures in elderly men: MrOS Sweden, J Bone Miner Res, 21, 529, 10.1359/jbmr.060110
Meier, 2008, Endogenous sex hormones and incident fracture risk in older men, Arch Intern Med, 168, 47, 10.1001/archinternmed.2007.2
Barrett-Connor, 2000, Low levels of estradiol are associated with vertebral fractures in older men, but not women: the Rancho Bernardo Study, J Clin Endocrinol Metab, 85, 219, 10.1210/jc.85.1.219
Amin, 2006, Estradiol, testosterone, and the risk for hip fractures in elderly men from the Framingham Study, Am J Med, 119, 426, 10.1016/j.amjmed.2005.10.048
Seeman, 1983, Risk factors for spinal osteoporosis in men, Am J Med, 75, 977, 10.1016/0002-9343(83)90878-1
Boonen, 1997, Age-related (type II) femoral neck osteoporosis in men: biochemical evidence for both hypovitaminosis D- and androgen deficiency-induced bone resorption, J Bone Miner Res, 12, 2119, 10.1359/jbmr.1997.12.12.2119
Leifke, 1998, Effects of testosterone replacement therapy on cortical and trabecular bone mineral density, vertebral body area and paraspinal muscle area in hypogonadal men, Eur J Endocrinol, 138, 51, 10.1530/eje.0.1380051
Finkelstein, 1996, A longitudinal evaluation of bone mineral density in adult men with histories of delayed puberty, J Clin Endocrinol Metab, 81, 1152, 10.1210/jc.81.3.1152
Bertelloni, 1998, Normal volumetric bone mineral density and bone turnover in young men with histories of constitutional delay of puberty, J Clin Endocrinol Metab, 83, 4280, 10.1210/jc.83.12.4280
Bertelloni, 1998, Altered bone mineral density in patients with complete androgen insensitivity syndrome, Horm Res, 50, 309, 10.1159/000023296
Mizunuma, 1998, Changes in bone mineral density after orchidectomy and hormone replacement therapy in individuals with androgen insensitivity syndrome, Hum Reprod, 13, 2816, 10.1093/humrep/13.10.2816
Labrie, 1997, Marked decline in serum concentration of adrenal C-19 sex steroid precursors and conjugated androgen metabolites during aging, Endocrinology, 82, 2396
Zborowski, 2000, Bone mineral density, androgens, and the polycystic ovary: the complex and controversial issue of androgenic influence, J Clin Endocrinol Metab, 85, 3496, 10.1210/jc.85.10.3496
Buchanan, 1988, Effect of excess endogenous androgens on bone density in young women, J Clin Endocrinol Metab, 67, 937, 10.1210/jcem-67-5-937
Bertelloni, 1997, Androgen-receptor blockade does not impair bone mineral density in adolescent females, Calcif Tissue Int, 61, 1, 10.1007/s002239900282
Prezelj, 1994, Antiandrogen treatment with spironolactone and linestrenol decreases bone mineral density in eumenorrheic women with androgen excess, Horm Metab Res, 26, 46, 10.1055/s-2007-1000771
Simberg, 1996, High bone density in hyperandrogenic women: effect of gonadotropin-releasing hormone agonist alone or in conjunction with estrogen-progestin replacement, J Clin Endocrinol Metab, 81, 646, 10.1210/jc.81.2.646
Moghetti, 1999, Spironolactone, but not flutamide, administration prevents bone loss in hyperandrogenic women treated with gonadotropin-releasing hormone agonist, J Clin Endocrinol Metab, 84, 1250, 10.1210/jc.84.4.1250
Barrett-Connor, 1993, A prospective study of dehydroepiandrosterone sulfate (DHEAS) and bone mineral density in older men and women, Am J Epidemiol, 137, 201, 10.1093/oxfordjournals.aje.a116660
Greendale, 1997, Endogenous sex steroids and bone mineral density in older women and men: the Rancho Bernardo study, J Bone Miner Res, 12, 1833, 10.1359/jbmr.1997.12.11.1833
Mauras, 1994, Calcium and protein kinetics in prepubertal boys. Positive effects of testosterone, J Clin Invest, 93, 1014, 10.1172/JCI117049
Behre, 1997, Long-term effect of testosterone therapy on bone mineral density in hypogonadal men, J Clin Endocrinol Metab, 82, 2386, 10.1210/jc.82.8.2386
Katznelson, 1996, Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism, J Clin Endocrinol Metab, 81, 4358, 10.1210/jc.81.12.4358
Wang, 1996, Sublingual testosterone replacement improves muscle mass and strength, decreases bone resorption, and increases bone formation markers in hypogonadal men—a clinical research center study, J Clin Endocrinol Metab, 81, 3654, 10.1210/jc.81.10.3654
Snyder, 2000, Effects of testosterone replacement in hypogonadal men, J Clin Endocrinol Metab, 85, 2670, 10.1210/jc.85.8.2670
Wang, 2001, Effects of transdermal testosterone gel on bone turnover markers and bone mineral density in hypogonadal men, Clin Endocrinol (Oxf), 54, 739, 10.1046/j.1365-2265.2001.01271.x
Guo, 1997, Treatment of isolated hypogonadotropic hypogonadism effect on bone mineral density and bone turnover, J Clin Endocrinol Metab, 82, 658, 10.1210/jc.82.2.658
Wang, 2000, Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men, Testosterone Gel Study Group, J Clin Endocrinol Metab, 85, 2839, 10.1210/jc.85.8.2839
Anderson, 1996, Androgen supplementation in eugonadal men with osteoporosis—effects of 6 months of treatment on bone mineral density and cardiovascular risk factors, Bone, 18, 171, 10.1016/8756-3282(95)00441-6
van den Bergh, 2001, Bone mineral density and quantitative ultrasound parameters in patients with Klinefelter's syndrome after long-term testosterone substitution, Osteoporosis Int, 12, 55, 10.1007/s001980170158
Finkelstein, 1989, Increases in bone density during treatment of men with idiopathic hypogonadotropic hypogonadism, J Clin Endocrinol Metab, 69, 776, 10.1210/jcem-69-4-776
Khosla, 1998, Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen, J Clin Endocrinol Metab, 83, 2266, 10.1210/jc.83.7.2266
Kenny, 2000, Determinants of bone density in healthy older men with low testosterone levels, J Gerontol A Biol Sci Med Sci, 55A, M492, 10.1093/gerona/55.9.M492
Snyder, 1999, Effect of testosterone treatment on bone mineral density in men over 65 years of age, J Clin Endocrinol Metab, 84, 1966, 10.1210/jc.84.6.1966
Kenny, 2001, Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels, J Gerontol A Biol Sci Med Sci, 56, M266, 10.1093/gerona/56.5.M266
Ly, 2001, A double-blind, placebo-controlled, randomized clinical trial of transdermal dihydrotestosterone gel on muscular strength, mobility, and quality of life in older men with partial androgen deficiency, J Clin Endocrinol Metab, 86, 4078, 10.1210/jc.86.9.4078
Reid, 1996, Testosterone therapy in glucocorticoid-treated men, Arch Intern Med, 156, 1173, 10.1001/archinte.156.11.1173
Bertelloni, 1995, Short-term effects of testosterone treatment on reduced bone density in boys with constitutional delay of puberty, J Bone Miner Res, 10, 1488, 10.1002/jbmr.5650101009
Raisz, 1996, Comparison of the effects of estrogen alone and estrogen plus androgen on biochemical markers of bone formation and resorption in postmenopausal women, J Clin Endocrinol, 81, 37, 10.1210/jc.81.1.37
Baulieu, 2000, Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge study to a sociobiomedical issue, Proc Natl Acad Sci USA, 94, 4279, 10.1073/pnas.97.8.4279
Villareal, 2000, Effects of DHEA replacement on bone mineral density and body composition in elderly women and men, Clin Endocrinol (Oxf), 53, 561, 10.1046/j.1365-2265.2000.01131.x
Nair, 2006, DHEA in elderly women and DHEA or testosterone in elderly men, N Engl J Med, 355, 1647, 10.1056/NEJMoa054629
Matzkin, 1992, Prolonged treatment with finasteride (a 5 α-reductase inhibitor) does not affect bone density and metabolism, Clin Endocrinol (Oxf), 37, 432, 10.1111/j.1365-2265.1992.tb02355.x
Tollin, 1996, Finasteride therapy does not alter bone turnover in men with benign prostate hyperplasia—a clinical research center study, J Clin Endocrinol Metab, 81, 1031, 10.1210/jc.81.3.1031
Issa, 2002, Human osteoblast-like cells express predominantly steroid 5α-reductase type 1, J Clin Endocrinol Metab, 87, 5401, 10.1210/jc.2001-011902
Taxel, 2001, The effect of aromatase inhibition on sex steroids, gonadotropins, and markers of bone turnover in older men, J Clin Endocrinol Metab, 86, 2869, 10.1210/jc.86.6.2869
Doran, 2001, Effects of raloxifene, a selective estrogen receptor modulator, on bone turnover markers and serum sex steroid and lipid levels in elderly men, J Bone Miner Res, 16, 2118, 10.1359/jbmr.2001.16.11.2118